Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-02-25 @ 5:53 PM
Study NCT ID:
NCT00659360
Status:
COMPLETED
Last Update Posted:
2018-06-29
First Post:
2008-04-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Adult Fibrosarcoma | View |
| None | Adult Leiomyosarcoma | View |
| None | Adult Liposarcoma | View |
| None | Adult Malignant Fibrous Histiocytoma | View |
| None | Adult Rhabdomyosarcoma | View |
| None | Dermatofibrosarcoma Protuberans | View |
| None | Endometrial Stromal Sarcoma | View |
| None | Recurrent Adult Soft Tissue Sarcoma | View |
| None | Recurrent Uterine Sarcoma | View |
| None | Stage III Adult Soft Tissue Sarcoma | View |
| None | Stage III Uterine Sarcoma | View |
| None | Stage IV Adult Soft Tissue Sarcoma | View |
| None | Stage IV Uterine Sarcoma | View |
| None | Uterine Carcinosarcoma | View |
| None | Uterine Leiomyosarcoma | View |
Keywords: